China Health Technology to Place 143 Million Shares for HK$9 Million

China Health Technology Group Holding (HKG:1069) plans to issue 143 million shares to six placees for about HK$9 million in gross proceeds under a general mandate, according to a Wednesday filing on t

MT NewswiresMay 28 21:44 ET

China Health Technology Group (01069) plans to sell a total of up to 143 million shares at a discount of about 13.70% to raise about HK$8.6 million

China Health Technology Group (01069) issued an announcement. On May 28, 2024 (after the trading period), the company...

Zhitong FinanceMay 28 18:18 ET

China Health Technology Group (01069) and Scura signed a strategic cooperation memorandum to jointly develop the R&D and sales business of ginseng extracted ion energy water in China

China Health Technology Group (01069) announced that on May 16, 2024, the company and Fujian Ningdes...

Zhitong FinanceMay 16 10:30 ET

Statutory Earnings May Not Be The Best Way To Understand China Health Technology Group Holding's (HKG:1069) True Position

Despite posting strong earnings, China Health Technology Group Holding Company Limited's (HKG:1069) stock didn't move much over the last week. We looked deeper into the numbers and found that shareho

Simply Wall StApr 9 18:31 ET

China Health Technology Group Terminates 52% Stake Acquisition Deal

China Health Technology Group Holding (HKG:1069) will terminate the acquisition deal for a 52% stake in a target company, according to a Hong Kong bourse filing on Monday. The termination is mutually

MT NewswiresApr 9 04:28 ET

China Health Technology Group (01069.HK) terminated the acquisition of 52% shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development

Gelonghui, April 8, 丨 China Health Technology Group (01069.HK) announced the acquisition of 52% of the shares in Liuba Jiashisen Traditional Chinese Medicine Comprehensive Development. After signing the share sale agreement, the company then carried out detailed due diligence and other work on the seller. However, at the company's request, the seller failed to provide satisfactory due diligence documentation to the company. Following friendly negotiations between the company and the seller, the contracting parties decided to terminate the acquisition. The Board believes that terminating the agreement will not have any significant adverse impact on the Group's business, operations, or financial position.

Gelonghui FinanceApr 8 10:14 ET